Opera (OPRA) Research & Development (2018 - 2026)

Opera has reported Research & Development for 9 years, with the latest figure at -$38.5 million in Q1 2026.

• Quarterly Research & Development fell 12.61% year-over-year to -$38.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$146.5 million (down 7.2% YoY) and the FY2025 annual result came in at -$142.2 million, down 7.78% from the prior year.
• Research & Development eased to -$38.5 million in Q1 2026 per OPRA's latest filing, from -$38.1 million in the prior quarter.
• Over five years, Research & Development peaked at -$27.0 million in Q2 2023 and troughed at -$29.6 billion in Q4 2022.
• A 5-year average of -$6.2 billion and a median of -$34.2 million in 2025 frame the typical range for Research & Development.
• The sharpest annual moves came in 2022 and 2023: Research & Development tumbled 98528.58% in 2022, then soared 99.9% in 2023.
• Over 5 years, Research & Development stood at -$29.6 billion in 2022, then jumped by 99.9% to -$30.1 million in 2023, then slumped by 35.81% to -$40.9 million in 2024, then rose by 6.88% to -$38.1 million in 2025, then declined by 1.02% to -$38.5 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered -$38.5 million, -$38.1 million, and -$35.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.